Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib
- Supplementary File 1:
PDF-Document (PDF, 400 KiB)
Ko, Y.-C.; Hu, C.-Y.; Liu, Z.-H.; Tien, H.-F.; Ou, D.-L.; Chien, H.-F.; Lin, L.-I. Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib. Int. J. Mol. Sci. 2019, 20, 1230. https://doi.org/10.3390/ijms20051230
Ko Y-C, Hu C-Y, Liu Z-H, Tien H-F, Ou D-L, Chien H-F, Lin L-I. Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib. International Journal of Molecular Sciences. 2019; 20(5):1230. https://doi.org/10.3390/ijms20051230
Chicago/Turabian StyleKo, Ya-Chen, Chung-Yi Hu, Zheng-Hau Liu, Hwei-Fang Tien, Da-Liang Ou, Hsiung-Fei Chien, and Liang-In Lin. 2019. "Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib" International Journal of Molecular Sciences 20, no. 5: 1230. https://doi.org/10.3390/ijms20051230